Serum proteomic analysis identifies interleukin 16 as a biomarker for clinical response during early treatment of rheumatoid arthritis.
| Image |  |
|---|---|
| Description | scientific article published on 14 December 2015 |
| Author/s | |
| Publication date | December 14, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |